COVID–19 Medical Production Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
COVID-19 Medical Production Act
This bill provides additional funding for FY2021 to acquire medical supplies, vaccines, and other equipment to combat COVID-19 (i.e., coronavirus disease 2019) using authorities under the Defense Production Act of 1950. That act confers on the President a broad set of authorities to influence domestic industry to provide essential materials and goods for the national defense.
This funding is available through FY2025. Beginning in FY2023, it may be used to meet public health needs to address any pathogen determined by the President to have the potential to create a public health emergency.
Referred to the House Committee on Financial Services.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 1720: COVID–19 Medical Production Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-1720/
"H.R. 1720: COVID–19 Medical Production Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-1720/.
H.R. 1720, 117th Cong. (2026), https://openamerica.io/bill/117-HR-1720/.
[H.R. 1720: COVID–19 Medical Production Act](https://openamerica.io/bill/117-HR-1720/)